{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T17:46:42Z","timestamp":1696096002268},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The aim of this study was to evaluate the pulmonary function test (PFT) abnormalities, if any, in children with newly diagnosed chronic hepatitis B (CHB) infection over 3 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is an observational case-control study. One hundred children and adolescents with newly diagnosed CHB were enrolled as the patient group that was further subdivided into 2 groups (50 patients each): inactive carriers (group I) and patients in immunotolerant phase (group II). Only 90 patients completed the study. Fifty healthy children of matched age, sex and height served as a control group, only 45 of them completed the study. PFTs in the form of forced expiratory volume in 1\u2009s (FEV<jats:sub>1<\/jats:sub>), forced vital capacity (FVC), FEV<jats:sub>1<\/jats:sub>\/FVC, residual volume, total lung capacity, mid-forced expiratory flow of 25%\u201375% and diffusing capacity of the lung for carbon monoxide were evaluated in all studied children at the start, yearly and at the end of the study after 3 years. Liver function tests were also evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>There was a significant progressive decrease in FEV<jats:sub>1<\/jats:sub>, FVC, forced expiratory flow, total lung capacity and diffusing capacity of the lung for carbon monoxide in CHB patient groups compared with their pulmonary functions at the start of the study and with the control group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05), while FEV<jats:sub>1<\/jats:sub>\/FVC and residual volume showed nonsignificant change (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Subclinical PFT abnormalities are present in children with CHB more than we expected. So, PFT monitoring is recommended in pediatric patients with CHB.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002543","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:30:16Z","timestamp":1574663416000},"page":"192-196","source":"Crossref","is-referenced-by-count":1,"title":["Chronic Hepatitis B Infection in Children and Its Relation to Pulmonary Function Tests: A Case-control Study"],"prefix":"10.1097","volume":"39","author":[{"given":"Doaa","family":"El Amrousy","sequence":"first","affiliation":[{"name":"Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Hassan","sequence":"additional","affiliation":[{"name":"Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"El Ashry","sequence":"additional","affiliation":[{"name":"Tropical Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jhep.2012.03.036","article-title":"Chronic hepatitis B in children and adolescents.","volume":"57","author":"Paganelli","year":"2012","journal-title":"J Hepatol"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3350\/kjhep.2011.17.2.87","article-title":"Epidemiology and prevention of hepatitis B virus infection.","volume":"17","author":"Kwon","year":"2011","journal-title":"Korean J Hepatol"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1158\/1078-0432.CCR-05-1095","article-title":"Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.","volume":"11","author":"Chang","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/92.14.1159","article-title":"Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives.","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.ijid.2011.10.009","article-title":"Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.","volume":"16","author":"Luo","year":"2012","journal-title":"Int J Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009.","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11894-001-0044-1","article-title":"Extrahepatic manifestations of chronic viral hepatitis.","volume":"3","author":"Pyrsopoulos","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"R8-20230912","first-page":"451","article-title":"The extrahepatic manifestations of hepatitis B virus.","volume":"18","author":"Baig","year":"2008","journal-title":"J Coll Physicians Surg Pak"},{"key":"R9-20230912","first-page":"30","article-title":"Extrahepatic manifestations of viral hepatitis: hospital based study.","volume":"159","author":"Amarapurkar","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.125.4.1368","article-title":"Increased responses to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection.","volume":"125","author":"Kanazawa","year":"2004","journal-title":"Chest"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjmed.2003.12.026","article-title":"Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study.","volume":"116","author":"Kanazawa","year":"2004","journal-title":"Am J Med"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0950268809990276","article-title":"Prevalence of hepatitis C virus infection in patients with COPD.","volume":"138","author":"Silva","year":"2010","journal-title":"Epidemiol Infect"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.dld.2006.05.013","article-title":"Pulmonary alterations in patients with chronic HCV infection.","volume":"38","author":"Erturk","year":"2006","journal-title":"Dig Liver Dis"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0953-6205(02)00066-3","article-title":"Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis.","volume":"13","author":"Teuber","year":"2002","journal-title":"Eur J Intern Med"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.124.1.406","article-title":"Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.","volume":"124","author":"Abi-Nassif","year":"2003","journal-title":"Chest"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-1536-1-2","article-title":"Viruses as co-factors for the initiation or exacerbation of lung fibrosis.","volume":"1","author":"Vannella","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.rmed.2014.10.006","article-title":"The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: a population based study from the NHANES III database.","volume":"108","author":"Goh","year":"2014","journal-title":"Respir Med"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.","volume":"115","author":"Deguchi","year":"2004","journal-title":"J Virol Methods"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/JCM.02046-07","article-title":"Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep\/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B.","volume":"46","author":"Ciotti","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/rccm.200903-0323OC","article-title":"Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative.","volume":"180","author":"Stanojevic","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes.","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1164\/ajrccm.155.1.9001318","article-title":"Adjustment of DLCO for hemoglobin concentration.","volume":"155","author":"Marrades","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20230912","first-page":"359","article-title":"A stepwise approach to the interpretation of pulmonary function tests.","volume":"89","author":"Johnson","year":"2014","journal-title":"Am Fam Physician"},{"key":"R26-20230912","first-page":"1345","article-title":"Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome\u201362 patients.","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jaut.2000.0502","article-title":"Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.","volume":"16","author":"Trepo","year":"2001","journal-title":"J Autoimmun"},{"key":"R28-20230912","first-page":"123","article-title":"Extrahepatic manifestations of acute hepatitis B virus infection.","volume":"9","author":"Kappus","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:16:03Z","timestamp":1694556963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002543","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}